Surf Bio announced today that it raised $16 million in seed funding to advance its drug delivery offerings for treating diabetes.
Palo Alto, California-based Surf Bio plans to use the funds to advance its polymer-based drug delivery platform and accelerate the development of ultra-rapid insulin for treating diabetes.
Get the full story at our sister site, Drug Delivery Business News.